LATEST ALERTS
The 2018 results from the Altria Group revealed a slump in sales of combustibles. The company is now turning its attention to alternative sectors such as cannabis and Juul, and preparing for the US launch of IQOS
A new bill proposed in Colombia’s Senate is paving the way for the country to begin regulating heated tobacco and vaping products on a par with combustible tobacco – though the plan is tied up in the country’s complex political arithmetic
The European Court of Justice (ECJ) has upheld the ban on the sale of snus which has applied since 1992 in the whole EU except Sweden, which was granted an exemption under the 2014 Tobacco Products Directive (TPD)
British American Tobacco (BAT) has lowered its expectations of its heated tobacco and vaping products this year – but still anticipates continuing growth
British American Tobacco (BAT) may get two heated-tobacco products onto the US market before IQOS can be launched there, thanks to its decision to take a different route to FDA approval
British American Tobacco (BAT) has a chance to steal a march on its Big Tobacco rivals in the heated-tobacco market after the company became the first to receive approval to sell a heat-not-burn device in the US
Imperial Brands will focus on its next generation portfolio and expand its e-cigarette Myblu into new markets in order to give itself a better alternative to traditional tobacco products
While sales of traditional cigarettes continue to decline worldwide, PMI is increasingly relying on its heated-tobacco device IQOS to buoy up its financial results, particularly through sales in Japan and Korea
Colombia’s health and finance ministries have moved to force heated tobacco products such as IQOS to comply with the country’s tobacco law, arguing there is no evidence to suggest that they present any lower risk than cigarettes
The US FDA has taken a step closer to regulating nicotine levels in combustible cigarettes, but excluded vapour products from its proposals, even predicting a low-nicotine regime might encourage smokers toward electronic alternatives
The US FDA has made some public amendments to PMI’s reduced risk applications for IQOS and three types of Marlboro HeatSticks products
British American Tobacco claims to be the largest reduced-risk product company in the world following its acquisition of Reynolds American and says it will build on this through a variety of HnB, moist tobacco and oral tobacco brands
As tobacco giants Philip Morris International (PMI) and Japan Tobacco (JT) have been hit by falling tobacco sales, revenues from their e-cigarette and heat-not-burn (HnB) portfolios have increased
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
As the US FDA gets to grips with its new focus on nicotine as a single marketplace, it is planning to take a fresh look at one of the longest-established non-combustible forms of the substance – nicotine replacement therapy
ECigIntelligence’s review of the year gone by reflects the big stories of the e-cigarette world in 2017, the trends in regulation, the developing and diverging markets, the science and innovation, and peers into the crystal ball to consider where it all goes from here
The US Food and Drug Administration (FDA) will have to consider again next year the possibility that snus could be a reduced-risk form of tobacco, following a series of applications from R.J. Reynolds Tobacco Company
E-cigarettes could be taxed at the same level as cigarettes if a new US proposal passes into law. TobaccoIntelligence believes this attempt is likely to fail
The US FDA has missed its own 180-day deadline for replying to the premarket tobacco application (PMTA) by Philip Morris International for its IQOS heated tobacco products
The American Vaping Association has written to FDA commissioner Scott Gottlieb urging him to approve PMI’s heated tobacco product iQOS for sale in the US
A move by the US FDA to reduce the nicotine content in cigarettes to non-addictive levels could encourage Big Tobacco to put yet more effort into alternatives
Scott Gottlieb, commissioner of the US FDA, appeared on Friday to go further than any federal official – or most politicians – previously had in supporting alternative nicotine products for harm reduction
The $49.4bn takeover of Reynolds American by British American Tobacco (BAT) is set to go through next week after being approved by shareholders of both companies.
New research shines a little light on how Japanese consumers are reacting to iQOS, and how HnB products compare with both combustibles and e-cigarettes on the crucial question of nicotine delivery.
PMI has responded forcefully after a Swiss research team claimed its iQOS heat-not-burn system released “the same harmful constituents of conventional cigarette smoke”
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Altria is set to take a digital approach to launching its iQOS heat-not-burn product in the U.S. but there will be significant costs along the way.
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk
Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA)
Pax Labs, the U.S. heat-not-burn manufacturer previously known as Ploom, today launches a new generation of its namesake device which it is positioning as “the most intelligent, premium and highest performing vaporizer in the market”.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
